Peters · Journal of Alzheimer's disease : JAD 2016 · in vitro comparative mechanistic study · n=?

Differential Membrane Toxicity of Amyloid-β Fragments by Pore Forming Mechanisms.

Cited 56 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

In vitro laboratory and mechanistic bench study without human subjects.

PubMed 26890761 · doi:10.3233/JAD-150896 · record verified 2026-08-28

What was done

The authors evaluated the mechanistic effects of three fragments derived from Aβ(1-42): N-terminal Aβ(1-28), central Aβ(25-35), and C-terminal Aβ(17-42). Their membrane and neuronal effects were evaluated in vitro using patch-clamp electrophysiology, immunofluorescence, transmission electron microscopy, peptide aggregation assays, intracellular calcium imaging, and MTT viability assays.

What was found

The abstract reports qualitative comparative observations without specific numerical data or effect sizes. Aβ(1-28) promoted peptide aggregation, increased intracellular calcium, and caused synaptotoxicity, but did not cause membrane perforation. Aβ(25-35) caused membrane perforation, intracellular calcium elevation, and synaptotoxicity. Aβ(17-42) induced mitochondrial toxicity similar to full-length Aβ(1-42), but did not induce membrane perforation or intracellular calcium elevation.

Why it matters

These findings delineate region-specific toxic mechanisms within the Aβ(1-42) peptide, isolating pore-forming membrane disruption specifically to the central Aβ(25-35) domain.

Limits

This is an in vitro bench investigation with no in vivo animal or human clinical data. The abstract provides no quantitative measurements, statistical comparisons, effect sizes, or sample sizes.

Cited by